Six years of petroleum geological activities in North-East Greenland (2008–2013): projects and a view of the future

The deadline for applications to the first licence round for petroleum exploration offshore North-East Greenland was 15 December 2012. The round was restricted, allowing only members of the KANUMAS consortium to be operators (BP, Chevron, Exxon, JOGMEG, Shell and Statoil). Nunaoil is also part of KANUMAS, but it is a carried, non-operator partner. An ordinary licensing round followed shortly after with a deadline on 15 October 2013

Age of oils in West Greenland: was there a Mesozoic seaway between Greenland and Canada?

For many years the existence of an oil-prone source rock off West Greenland was challenged by industry. But since 1992 when active oil seeps were found onshore West Greenland on the Nuussuaq peninsula (Fig. 1; Christiansen et al. 1996; Bojesen-Koefoed et al. 1999), the question has changed focus to the age, distribution and potential of the source rock. Five different oils – each with their own characteristics – have been reported by the Geological Survey of Denmark and Greenland (GEUS). One of these, a typical marine shalederived oil with a possible regional distribution, is known as the Itilli oil. Geochemical analysis suggests that it may have been generated from Cenomanian–Turonian age marine shales, equivalent to prolific source rocks known from Ellesmere Island, Nunavut, Canada. Three of the other oils were generated from deltaic source rocks of Albian, Campanian and Paleocene ages, while one is of unknown origin (Bojesen-Koefoed et al. 1999). The presence of a regional marine source rock is important to petroleum exploration; GEUS has therefore investigated the possible existence of Mesozoic, in particular Cenomanian–Turonian, petroleum source rocks in West Greenland offshore areas. Since sediments older than the Santonian are not known from any of the six wells drilled offshore West Greenland (Fig. 1), assessment of oil-prone source rocks in older sedimentary successions must rely on circumstantial evidence offered by oil chemistry data and analogy studies. Petroleum in quantities amenable to chemical analysis has so far not been recovered from offshore. However, oilbearing fluid inclusions are known from the Ikermiut-1 well (unpublished data 2001, Phillips Petroleum and GEUS), a gas-kick was recorded during drilling of the Kangâmiut-1 well (Bate 1997), and seismic data indicate hydrocarbons in many areas (cross-cutting reflectors, bright spots, smearing of seismic). Petroleum exploration offshore West Greenland suffered for many years under the misconception that oceanic crust covered vast areas, rendering the region unattractive. However, the presence of thick sedimentary successions and rotated fault blocks in Cretaceous basins have been demonstrated to be present in areas previously believed to be underlain by Cretaceous–Tertiary oceanic crust (cf. Chalmers & Pulvertaft 2001). New high-quality seismic data, acquired by the seismic company TGS-NOPEC over recent years, combined with gravimetric data, have further demonstrated the presence of deep basins containing thick sedimentary successions in other areas (e.g. Christiansen et al. 2002). Despite the progress made over the past few years, the geological evolution of the Davis Strait region in general remains poorly understood, but new data on oil chemistry may shed some light on the history of this region

QUINOLONE- AND ETA-LACTAM- RESISTANCE IN Escherichia coli FROM DANISH AND ITALIAN BROILER FLOCKS

The prevalence of quinolone- and -lactam-resistant E. coli was investigated among healthy broiler flocks in Denmark and Italy. In Denmark, sock samples were collected from 10 parent flocks and 10 offspring flocks, according to the procedure currently used for the surveillance of Salmonella in the EU. Samples were enriched in McConkey broth and streaked on McConkey agar plates added with nalidixic acid (32 g/ml), ciprofloxacin (2 g/ml), ampicillin (32 g/ml), cefotaxime (2 g/ml) or ceftiofur (8 g/ml). The -glucuronidase test was performed for verification of presumptive E. coli. The same methods were used to analyse sock samples collected from 6 Italian broiler flocks. PCR with primers for the CTX-M-type extended-spectrum -lactamases (ESBLs) was performed on cephalosporin-resistant isolates. While resistance to ampicillin and nalidixic acid was widespread in both countries, resistance to ciprofloxacin and cephalosporins was more common among Italian flocks. In Denmark, ciprofloxacin resistance was only detected in 1 parent flock without any history of quinolone usage and none of the flocks was positive for cephalosporin-resistant E. coli. In Italy, resistance to ciprofloxacin was detected in all flocks and resistance to ceftiofur and cefotaxime were detected in 5 flocks. Primers specific for the CTX-M-type ESBLs generated PCR amplicons from isolates from 3 of these flocks. In industrialized countries, the poultry production system is highly standardized, and therefore comparable. However, the use of broad-spectrum antimicrobials is particularly limited in Danish poultry production. Accordingly, the results of this study could reflect the different policies in antimicrobial usage between the two countries

No association of breast cancer risk with integrin beta3 (ITGB3) Leu33Pro genotype

To pursue a borderline increased risk of breast cancer for carriers of two integrin beta3 (ITGB3) 33Pro alleles found in a recent prospective study, we conducted a case–control study of 1088 women with breast cancer and 4815 female controls. Leu33Pro heterozygotes, homozygotes and heterozygotes+homozygotes vs noncarriers had odds ratios for breast cancer of 1.0 (95% confidence interval: 0.8–1.1), 0.8 (0.5–1.2) and 1.0 (0.8–1.1), respectively. After stratification for conventional risk factors, odds ratio for breast cancer in heterozygotes, homozygotes and heterozygotes+homozygotes vs noncarriers were not increased above 1.0 in any of the 14 strata examined. This was also true after stratification for tumour histological subtype and cancer stage at the time of diagnosis

Development and validation of a model to predict incident chronic liver disease in the general population: the CLivD score

BACKGROUND & AIMS: Current screening strategies for chronic liver disease focus on detection of subclinical advanced liver fibrosis but cannot identify persons at high future risk for severe liver disease. Our aim was to develop and validate a risk prediction model for incident chronic liver disease in the general population based on widely available factors. METHODS: Multivariable Cox regression analyses were used to develop prediction models for liver-related outcomes with and without laboratory measures (Modellab and Modelnon-lab) in 25,760 individuals aged 40-70 years. Their data were sourced from the Finnish population-based health examination surveys FINRISK 1992-2012 and Health 2000 (derivation cohort). The models were externally validated in the Whitehall II (n = 5058) and Copenhagen City Heart Study (CCHS) (n = 3049) cohorts. RESULTS: The absolute rate of incident liver outcomes per 100,000 person-years ranged from 53 to 144. The final prediction model included age, sex, alcohol use (drinks/week), waist-hip ratio, diabetes, and smoking, and Modellab also included gamma-glutamyltransferase values. Internally-validated Wolbers' C-statistics were 0.77 for Modellab and 0.75 for Modelnon-lab, while apparent 15-year AUCs were 0.84 (95% CI 0.75-0.93) and 0.82 (95% CI 0.74-0.91). The models identified a small proportion (10% absolute 15-year risk for liver events. Of all liver events, only 10% occurred in participants in the lowest risk category. In the validation cohorts, 15-year AUCs were 0.78 (Modellab) and 0.65 (Modelnon-lab) in the CCHS cohort, and 0.78 (Modelnon-lab) in the Whitehall II cohort. CONCLUSIONS: Based on widely available risk factors, this Chronic Liver Disease (CLivD) score can be used to predict risk for future advanced liver disease in the general population. LAY SUMMARY: Liver disease often progresses silently without symptoms and thus the diagnosis is often delayed until severe complications occur and prognosis becomes poor. In order to identify individuals in the general population who have high risk of developing severe liver disease in the future, we developed and validated a Chronic liver disease (CLivD) risk prediction score, based on age, sex, alcohol use, waist-hip ratio, diabetes, smoking, with or without gamma-glutamyltransferase (GGT). The CLivD score can be used as part of health counseling, and for planning further liver investigations and follow-up

Development and validation of a model to predict incident chronic liver disease in the general population : The CLivD score

Background & Aims: Current screening strategies for chronic liver disease focus on detection of subclinical advanced liver fibrosis but cannot identify those at high future risk of severe liver disease. Our aim was to develop and validate a risk pre-diction model for incident chronic liver disease in the general population based on widely available factors. Methods: Multivariable Cox regression analyses were used to develop prediction models for liver-related outcomes with and without laboratory measures (Modellab and Modelnon-lab) in 25,760 individuals aged 40-70 years. Their data were sourced from the Finnish population-based health examination surveys FINRISK 1992-2012 and Health 2000 (derivation cohort). The models were externally validated in the Whitehall II (n = 5,058) and Copenhagen City Heart Study (CCHS) (n = 3,049) cohorts. Results: The absolute rate of incident liver outcomes per 100,000 person-years ranged from 53 to 144. The final prediction model included age, sex, alcohol use (drinks/week), waist-hip ratio, diabetes, and smoking, and Modellab also included gamma-glutamyltransferase values. Internally validated Wolbers' C -sta-tistics were 0.77 for Modellab and 0.75 for Modelnon-lab, while apparent 15-year AUCs were 0.84 (95% CI 0.75-0.93) and 0.82 (95% CI 0.74-0.91). The models identified a small proportion ( 10% absolute 15-year risk for liver events. Of all liver events, only 10% occurred in participants in the lowest risk category. In the validation cohorts, 15-year AUCs were 0.78 (Modellab) and 0.65 (Modelnon-lab) in the CCHS cohort, and 0.78 (Modelnon-lab) in the Whitehall II cohort. Conclusions: Based on widely available risk factors, the Chronic Liver Disease (CLivD) score can be used to predict risk of future advanced liver disease in the general population. Lay summary: Liver disease often progresses silently without symptoms and thus the diagnosis is often delayed until severe complications occur and prognosis becomes poor. In order to identify individuals in the general population who have a high risk of developing severe liver disease in the future, we developed and validated a Chronic Liver Disease (CLivD) risk prediction score, based on age, sex, alcohol use, waist-hip ratio, diabetes, and smoking, with or without measurement of the liver enzyme gamma-glutamyltransferase. The CLivD score can be used as part of health counseling, and for planning further liver investigations and follow-up. (C) 2022 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.Peer reviewe